Gilead and Merck report positive phase three trial results for weekly HIV

The record

Written from the 1 report below. Nothing here is unsourced.

Gilead Sciences and Merck have reported positive Phase 3 clinical trial results for a weekly HIV treatment combination.
Phase 3 trials test a treatment in large groups of patients to confirm its safety and effectiveness.
The findings are due to be presented at the 26th International AIDS Conference in Rio de Janeiro.

Full trial data and safety details to be presented at the International AIDS Conference in Rio de Janeiro
Next steps toward regulatory approval of the weekly HIV treatment

1 report

English national1

All filed from India

Named Brazil · 26th International AIDS Conference · Gilead Sciences · Merck

The 1 report is listed beside the record.

Answers cite the reports above, or say they can't.